Topic overview

Start with the big picture

Adrenergic antagonists include alpha-blockers, beta-blockers, and mixed alpha/beta-blockers. Alpha-blockers vary by receptor selectivity: non-selective agents block α₁ and α₂ receptors, while selective α₁ blockers are used in settings such as hypertension and benign prostatic hyperplasia. Beta-blockers reduce heart rate, contractility, and renin release through competitive beta-receptor inhibition; their uses include cardiovascular conditions and selected non-cardiac indications. Drug selection also depends on properties such as beta-receptor selectivity and duration of action. Important safety considerations include orthostatic hypotension with alpha-blockers and bradycardia, bronchospasm, and masking of hypoglycemia with beta-blockers. The deeper lesson connects these classifications and mechanisms to clinical indications, adverse effects, and cautions.